Arbutus Biopharma Corp (ABUS)

CapEx to Revenue

0.00%

Quarterly · Period ending:

ABUS logo

ABUS CapEx to Revenue

Latest reported0.00%
ABUS Quarterly CapEx/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

ABUS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
5.4638%
0.0306%
0.0579%
6.201%
0.5903%
0.687%
18.4691%
1.7497%
2.1457%
1.5289%
1.4887%
0.5961%
1.8091%
0.5988%
27.1361%
4.6853%
6.3705%
0.7223%
4.3593%
0%
3.8937%
8.3306%
36.7534%
4.5655%
13.528%
14.9338%
34.164%
17.2702%
7.4191%
7.8062%
300.385%
1,456.5957%
-1,332.8205%
21.7054%
308.7379%
45.7711%
9.2543%
14.4895%
11.2647%
3.0115%
7.4253%
3.4846%
13.5837%
7.5621%
2.5853%
4.0363%
7.4172%
9.4083%
0.051%
0%
0.3295%
0.0235%
0.1049%
0.0969%
0.0314%
1.2722%
0.5057%
0.8903%
7.5335%
22.4081%
12.9395%
9.0868%
4.0177%
27.7665%
14.8267%
5.8856%
12.4571%
11.0642%
5.6511%
4.4059%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.